Clinical Trials Browser

Head and Neck Neoplasms × Venlafaxine Hydrochloride × Clear all

NCT04977271 2025-02-04

Mood Disorders in Head and Neck Cancer Patients

Phase 4 Withdrawn

Depressive Disorder, Head and Neck Neoplasms

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Phase 2 Withdrawn

Depression, Head and Neck Neoplasms